Artwork for podcast PeDRA Pearls
Points of Discussion: Should JAK Inhibitors be Considered for First-Line Therapy in the Treatment of AD in Children? Episode 1
31st January 2022 • PeDRA Pearls • Pediatric Dermatology Research Alliance
00:00:00 00:22:04

Share Episode

Shownotes

JAK Inhibitors versus Traditional Therapies

Moderated by Minnelly Luu, MD, this Points of Discussion series features guest speakers Amy Paller, MD, Elaine Siegfried, MD, A. Yasmine Kirkorian, MD, and Jeff Yu, MD. Listen as the group discusses whether or not they would prescribe oral JAK inhibitors over traditional therapies for the treatment of moderate-to-severe atopic dermatitis in children. They discuss the cases in which they have done so and why.

Links